Total Funding
60
63
Total FundingSeries C raised
Growth Score
-3 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
67658
Hinova Pharma is a pharmaceutical company.
- Frank Perabo: Chief Medical OfficerPast Role: ESSA Pharma, CMO
- Yuanwei Chen: Founder and Chief Executive Officer
About the Company
Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by using drug discovery systems such as medicinal chemistry, biological screening, process research, quality research, clinical reporting, and clinical research. Drugs, HC-1102 androgen receptor
inhibitors and other products, for the treatment of advanced prostate cancer and breast cancer.
